by TractManager | Jun 23, 2020 | COVID-Articles, Health Technology Assessment
Focus of the Report: This report focuses on electronic monitoring (EM) of hand hygiene (HH) in a hospital setting. Technology Description: Electronic HH monitoring systems vary in their degree of sophistication. The simplest are straightforward counters that record...
by TractManager | Jun 16, 2020 | COVID-Articles, Emerging Technology Report
Chloroquine (and its metabolite, hydroxychloroquine) is an oral 4-aminoquinoline antimalarial agent that has demonstrated antiviral effects on SARS-CoV and SARS-CoV-2 in vitro. It is being evaluated for the treatment of COVID-19.If you have a Hayes login, click here...
by TractManager | May 28, 2020 | COVID-Articles, Emerging Technology Report
Remdesivir is an investigational, intravenously administered antiviral agent proposed for treatment of COVID-19.If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | May 13, 2020 | COVID-Articles, Emerging Technology Report
Chloroquine (and its metabolite, hydroxychloroquine) is an oral 4-aminoquinoline antimalarial agent that has demonstrated antiviral effects on SARS-CoV and SARS-CoV-2 in vitro. It is being evaluated for the treatment of COVID-19.If you have a Hayes login, click here...
by TractManager | Apr 13, 2020 | COVID-Articles, Emerging Technology Report
Lopinavir/ritonavir is an oral antiretroviral protease inhibitor combination agent under investigation for the treatment of COVID-19. Lopinavir/ritonavir is FDA approved for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in...
by TractManager | Apr 9, 2020 | COVID-Articles, Emerging Technology Report
Convalescent plasma is a form of passive antibody therapy that is under investigation for the treatment of COVID-19. Convalescent plasma is collected from patients who have recovered from COVID-19 and administered to patients with active, symptomatic disease via...
Recent Comments